79P Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; p. S1406
Main Authors Mazzarella, L., Giugliano, F., Crimini, E., Uliano, J., Corti, C., D'Amico, P., Trillo Aliaga, P., Valenza, C., Repetto, M., Nicolo, E., Antonarelli, G., Ascione, L., Vivanet, G., Berton Giachetti, P.P.M., Belli, C., Criscitiello, C., Esposito, A., Locatelli, M.A., Minchella, I., Curigliano, G.
Format Journal Article
LanguageEnglish
Published 01.12.2021
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2021.10.097